LUGANO, Switzerland, September 9, 2016 (LifeSiteNews) — Ovarian cancer deaths were down considerably worldwide from 2002 to 2012 and a new study attributes this decrease to oral contraceptive use.
Those numbers are expected to keep dropping in the United States, Europe, and Japan through the next several years, according to the study, but the results don’t reflect the myriad risks of hormonal birth control or mention its potentially abortifacient effects.
The chief cause of the decline in deaths from ovarian cancer during those years was oral contraceptive use and the long-term resistance to ovarian cancer it provides, say the authors of the European Society for Medical Oncology study. They also believe the decrease in hormone replacement therapy (HRT), better diagnosis, and treatment could also be factors.
The U.S. saw a drop of 16 percent in the death rate, Europe was down 10 percent, and Japan, which has had a lower death rate than other countries, dipped 2 percent.
And despite these numbers showing a reduction in ovarian cancer from use of the pill, hormonal contraception increases the risk of many other types of cancer.
The federal government’s own statistics show the increased risk of breast, liver, and cervical cancer from the pill.
Increased risk through taking the pill of such conditions as stroke, brain shrinkage, blood clots, Crohn’s disease, miscarriage, drop in bone density, damaged fertility, hair loss, hardening of the arteries, and death has long been documented.
And more recently the June 2016 Journal of the American Dental Association said women on the pill are almost twice as likely to develop dry sockets as women not taking hormonal contraceptives.
More information on the many health risks from taking chemical contraceptives is available HERE.